Reports for LAMIVUDINE

Ingredient

LAMIVUDINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HEPTOVIR 5MG SOLUTION Resolved 2017-08-10 2017-09-13 18727
KIVEXA 600MG 300MG TABLET Resolved 2019-01-30 2019-03-15 74011
APO-LAMIVUDINE 150MG TABLET Resolved 2017-03-11 2017-05-16 664
APO-LAMIVUDINE 300MG TABLET Resolved 2017-07-11 2017-08-31 15271
APO-LAMIVUDINE 300MG TABLET Resolved 2021-02-26 2021-06-28 134757
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2017-10-12 2018-10-03 25829
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2018-02-06 2018-08-24 38860
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-03-04 2022-06-23 77526
PMS-ABACAVIR-LAMIVUDINE 600MG 300MG TABLET Resolved 2019-03-04 2022-06-23 77531
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699

Showing 1 to 10 of 26

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HEPTOVIR 5MG SOLUTION To be discontinued 2022-05-13 2022-05-13 160503
HEPTOVIR 100MG TABLET To be discontinued 2022-05-13 2022-05-13 160500
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
TRIZIVIR 300MG 300MG 150MG TABLET Discontinued 2019-09-18 2019-09-18 94278
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260

Showing 1 to 7 of 7